LabCorp Appoints New CMO
Brecher is a member of the editorial boards of Transfusion and Blood Therapies in Medicine and is an associate editor of the Journal of Clinical Apheresis. He is

Brecher is a member of the editorial boards of Transfusion and Blood Therapies in Medicine and is an associate editor of the Journal of Clinical Apheresis. He is

The Astellas tender offer represents a 41% premium to CV Therapeutics’s closing share price on January 26, 2009, the day prior to the public disclosure of Astellas’s proposal,

Under its bid, Cephalon intends to offer A$1.40 cash for each Arana ordinary share cum dividends and other rights. The total offer value is approximately A$318 million. The

Abstral is expected to be launched during the second half of 2009 in France and Spain, following pricing and reimbursement negotiations with the relevant authorities, by ProStrakan, Orexo’s

According to the company, the Bioguard will offer surgeons, wound care clinicians, infection control experts and primary care doctors a new weapon against the transmission of such virulent

The divestiture of the Unomedical wound care and ophthalmics business was a requirement of the European Commission following the acquisition of ConvaTec by Nordic Capital and Avista Capital

The exclusive license in EU countries other than France covered the distribution of Loramyc, a muco-adhesive buccal tablet for treating in oropharyngeal candidiasis, a type of infected mucositis,

The FDA approval is based on results from two pivotal clinical trials, Shine (six-month) and Sun (12-month), which found Symbicort significantly improved lung function within five minutes of

Cyclonatix manufactures clean and energy-saving electric motor systems for traction motors such as electric bicycle, electric scooter and electric motorcycle. Scott Sand, CEO and chairman of the board

The Center of Excellence (COE) is the second Singapore-based facility of its kind opened by PerkinElmer in the past year. The center will serve as a training and